Document ID: chunk:federal_register_of_legislation:F2024N01149:schedule:1:p3
Version: federal_register_of_legislation:F2024N01149
Segment Type: schedule
Provision Reference: sch 1 (pt 3/6)
Character Range: 12752–17067

pharmaceutical benefit; and
                (d)                 the day, month and year of the date (the stop date) to stop administering the pharmaceutical benefit; and
                (e)                 specified duration or indication that medicine is to be supplied for duration of chart; and
                (f)                  Authority Prescription Number; and
                (g)                 Closing the Gap (CTG); and
                (h)                 PBS/RPBS; and
                (i)                  additional instructions (if any) to be added by the medical practitioner, expressed as 'Additional Instructions'; and
                (j)                  Blood Glucose Level (BGL) range for administration; and
            8.2               Information requirements for a pharmaceutical benefit that is insulin and is not required to be administered PRN (as required) must also include a record of each administration of the benefit including the following:
                (a)                 date and time; and
                (b)                 units/dose; and
                (c)                 Blood Glucose Level recording and charting of:
                    (i)      date and time; and
                    (ii)    Blood Glucose Level.
                (d)                 credentials of the first nurse authorising and administering the pharmaceutical benefit; and
                (e)                 credentials of the second nurse authorising and administering the pharmaceutical benefit.

      9.      Insulin PRN (as required) pharmaceutical benefits

            9.1               The information requirements for a pharmaceutical benefit that is insulin required to be administered PRN (as required) must include the following:
                (a)             particulars sufficient to identify the pharmaceutical benefit, in line with Pharmaceutical Benefits Scheme Prescribing requirements, pharmaceutical dose, form, strength and units; and
                (b)                 the pharmaceutical benefit's:
                    (i)                  date and time of prescribing; and
                    (ii)                route of administration; and
                (c)                 the day, month and year of the date (the start date) to start administering the pharmaceutical benefit; and
                (d)                 the day, month and year of the date (the stop date) to stop administering the pharmaceutical benefit; and
                (e)                 specified duration or indication that medicine is to be supplied for duration of chart; and
                (f)                  Closing the Gap (CTG); and
                (g)                 PBS/RPBS; and
                (h)                 the maximum dose in 24 hours; and
            9.2               Information requirements for a pharmaceutical benefit that is insulin required to be administered PRN (as required) must also include a record of each administration of the benefit including the following:
                (a)                 date and time; and
                (b)                 units/dose; and
                (c)                 Blood Glucose Level recording and charting of:
                    (i)                  date and time; and
                    (ii)                Blood Glucose Level.
                (d)                 credentials of the first Nurse authorising and administering the pharmaceutical benefit.

      10.  PRN (as required) pharmaceutical benefits

            10.1            The information requirements for a pharmaceutical benefit, other than insulin, that is required to be administered PRN (as required) must include the following:
                (a)                 particulars sufficient to identify the pharmaceutical benefit, in line with Pharmaceutical Benefits Scheme Prescribing requirements, pharmaceutical dose, form and strength; and
                (b)                 the pharmaceutical benefit's:
                    (i)                  date and time of prescribing; and
                    (ii)                dose; and
                    (iii)              route of administration; and
                    (iv)              frequency of administration; and
                    (v)                 site of administration (if